{Title}

Bio€quity Europe

21st Annual Bio€quity Europe



April 13 - 14, 2021 | Dublin

LOCATION

The Convention Centre Dublin
Spencer Doc, N Wall Quay
Dublin, Ireland

Dublin Travel & Hotel Information

To plan your visit and make hotel reservations, please click here

Save up to €200.00 when you book by 29 January


Bio€quity Europe New Dates Announced:
BioCentury, EBD Group and the Dublin Regional Host Committee are pleased to announce the new dates for Bio€quity Europe. The Organizers will hold the event on April 13-14, 2021 and the conference will remain at The Convention Centre Dublin.

Bio€quity Europe is the industry’s premier international showcase for financial dealmakers and pharmaceutical executives to assess and network with rising biotechs.

For our 21st anniversary meeting, more than 80 hand-picked companies will present their stories and participate in the thought-leading program. The agenda will allow for maximum financial networking through both ample breaks, receptions, and 1x1 meetings using EBD Group’s partneringONE® conference networking solution.

Don’t miss this opportunity to potentially find your next blockbuster investment or partnership opportunity.

Insights Partner McKinsey & Co. will be returning to Bio€quity Europe to release its 2nd European Biotech conference report. Please click here to download the 2019 report “Biotech in Europe: Scaling Innovation".

BEE 2019 Attendees


Return to Conferences List
SCHEDULE
08:00  to  17:00
Coming soon
The Convention Centre Dublin
PRESENTERS

For information on becoming a Presenting Company, please email Eric Pierce.

  • Abarceo Pharma AB
  • Acesion Pharma
  • ADCendo ApS
  • ADmit Therapeutics S.L.
  • Aelin Therapeutics
  • Aelix Therapeutics S.L.
  • AGILeBiotics B.V.
  • Allcyte GmbH
  • Algenex S.L.
  • ANeuroTech
  • Anjarium Biosciences AG
  • Antag Therapeutics ApS
  • Apeiron Biologics AG
  • Atriva Therapeutics GmbH
  • Augustine Therapeutics
  • Cardior Pharmaceuticals GmbH
  • Confo Therapeutics N.V.
  • DCPrime B.V.
  • Eligo Bioscience S.A.S.
  • Ermium Therapeutics
  • eTheRNA immunotherapies N.V.
  • ethris GmbH
  • Evaxion Biotech
  • Forendo Pharma
  • Galecto Biotech AB
  • Glycostem Therapeutics
  • HalioDx S.A.S.
  • Hil Applied Medical Ltd
  • Ilya Pharma AB
  • ImCheck Therapeutics S.A.S.
  • Immunic Inc.
  • Io Biotech Aps
  • ISA Pharmaceuticals B.V.
  • KaNDy Therapeutics Ltd.
  • Kintai Therapeutics Inc.
  • Laboratoris Sanifit S.L.
  • Leucid Bio Ltd.
  • LNC Therapeutics
  • Microbiotica Ltd.
  • miDiagnostics N.V.
  • MiNA Therapeutics
  • Minoryx Therapeutics
  • MRM Health N.V.
  • Novadip Biosciences
  • Novadiscovery
  • Numab Therapeutics AG
  • Oasmia Pharmaceutical AB
  • Oncurious N.V.
  • Orexia Ltd.
  • Oryzon Genomics S.A.
  • Osivax
  • Oxurion N.V.
  • PDC*line Pharma
  • PhagoMed Biopharma GmbH
  • Pneumagen Ltd.
  • Polyneuron Pharmaceuticals AG
  • Prilenia Therapeutics
  • Promethera Biosciences
  • Q3 Medical Devices Ltd.
  • Refuge Biotechnologies Inc.
  • Rejuvenate Biomed Nv
  • Rewind Therapeutics
  • Rinri Therapeutics Ltd.
  • Scancell Holdings plc
  • siRNAgen Therapeutics Corp.
  • Step Pharma
  • Topas Therapeutics
  • Transcenta Holding Ltd.
  • UGISense AG
  • Valo Therapeutics Ltd.
  • Vaximm AG
  • Vivoryon Therapeutics AG
  • Yukin Therapeutics
SPONSORS

For information on becoming a Sponsor, please email Eric Pierce.

ORGANIZERS

  • {title}
  • {title}

FOUNDING SPONSOR

  • {title}

INSIGHTS PARTNER

  • {title}

REGIONAL HOST COMMITTEE

  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}

GOLD SPONSOR

  • {title}

SILVER SPONSORS

  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}

SUPPORTING PARTNERS

  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}

FACULTY
Joshua Berlin

Joshua Berlin

Executive Director, New Ventures
BioCentury
Karen Bernstein, Ph.D.

Karen Bernstein, Ph.D.

Chairman
BioCentury
Simone Fishburn, Ph.D.

Simone Fishburn, Ph.D.

Editor in Chief
BioCentury
David Flores

David Flores

President & CEO
BioCentury
Eric Pierce

Eric Pierce

Publisher
BioCentury
Jorge Santos da Silva, Ph.D.

Jorge Santos da Silva, Ph.D.

Partner
McKinsey & Company
Antoine Papiernik

Antoine Papiernik

Managing Partner & President
Sofinnova Partners